Biognosys | Next-Generation Proteomics
Contact us Helpdesk

Transforming life sciences with next-generation proteomics

The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making.

OUR STORY

Close in on your research and clinical development goals with Large-Scale Discovery Proteomics

Biognosys turned proteomics into a true discovery technology with unprecedented precision, depth, and scale. Our industry-leading proteome coverage and high-throughput facility enable simultaneous quantification of thousands of proteins across thousands of samples. Through our proprietary technology and advanced data analytics capabilities we generate actionable insights for R&D and clinical research.

LARGE-SCALE PROTEOMICS

Our Solutions

Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development.

OUR SERVICES

We offer a complete suite of software solutions for any mass spectrometry proteomics application in industry or academic life sciences research.

OUR SOFTWARE

Our kits and reagents for sample preparation, quantification and quality control empower researchers to apply cutting-edge proteomics in-house.

OUR KITS

Latest News & Stories

News
Biognosys Announces New Release of Spectronaut™

  15 June 2021 – SCHLIEREN (Zürich – Switzerland) The leading software solution for DIA proteomics is compatible with MS instruments from all major vendors, including[...]

READ MORE
Resource
Spectronaut™ 15: Expand Biological Insights with DIA Proteomics

Spectronaut 15 comes with many novel and enhanced features for the most complete and versatile quantitative proteomics[...]

READ MORE
News
Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer

Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announces today the appointment of Kristina Beeler as Chief Business[...]

READ MORE
News
Biognosys Announces Strategic Agreement with Siemens Healthineers

The Agreement Aims to Accelerate the Continuum of Diagnostic Biomarker Discovery through to Assay Development and Clinical[...]

READ MORE
Blog
How can large-scale discovery proteomics help drug research and development?

What is large-scale discovery proteomics? Proteomics has the potential to bring about transformative changes in our understanding of biology and the therapeutic targets linked[...]

READ MORE
Conference
AACR Annual Meeting 2021

At this year’s AACR Virtual Annual Meeting, Biognosys is proud to present a minisymposium, highlighting our work with AstraZeneca and ETH Zurich on the use of a novel[...]

READ MORE
News
Biognosys Announces Development Roadmap for Large-Scale Discovery Proteomics in Plasma

Through this development, Biognosys continues to advance industry standards for specificity and depth in[...]

READ MORE
Blog
Proteomics Meets Health Data Analytics

Advances in data science enable proteome data at a large-scale to be combined with other biodata and electronic patient health records, generating revolutionary novel insights for[...]

READ MORE
News
Biognosys Announces Appointment of Karel Novy as Chief Operating Officer

Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announces today the appointment of Karel Novy, PhD as Chief Operating[...]

READ MORE
News
Biognosys Announces Facility Expansion to Support Large-Scale Proteomics

Biognosys announces an expansion of its facilities with an additional office and laboratory 900 square meters (9687 sqft) site in the Bio-Technopark at Wagistrasse 18, Schlieren,[...]

READ MORE

Join Email List

    Select any of the below topic preferences: By submitting this form, you confirm that you agree to the processing of your personal data by Biognosys as described in the Privacy Policy.

    Join the Biognosys email list to receive news and exclusive content.

    Join Email List

      Select any of the below topic preferences: By submitting this form, you confirm that you agree to the processing of your personal data by Biognosys as described in the Privacy Policy.